Córdoba, January 2nd 2016. VivaCell Biotechnology España reinforces its R&D strategy with the project BIOMAP (Biomolecules design through multivariate analysis process for obtaining active compounds). The partners of the project also are Vaxdyn SL and Bionaturis (Bioorganic Research and Services S.A), under the coordination of Laboratorios Rovi SA. The VivaCell main aim is to develop new cannabinoid derivatives with therapeutic potential in the treatment of neuroinflammatory diseases. The project BIOMAP (RTC-2015-3364-1), initiated in 2015, shall last two years with a budget of 200.652 €. It is funded by CDTI within the program Feder-Interconecta 2015, with the support of MINECO and cofounded by European Regional Development Fund (ERDF).